ALEXANDRIA, Va., Feb. 26 -- United States Patent no. 12,234,218, issued on Feb. 25, was assigned to PRAGMA Therapeutics (Archamps, France).
"Heterocyclic compounds as modulators of mGluR7" was invented by Guillaume Duvey (Thyez, France) and Sylvain Celanire (Reignier-Esery, France).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to novel heterocyclic compounds. The invention is also directed to compounds which are modulators of the metabotropic glutamate receptors (mGluR), preferably of the metabotropic glutamate receptor subtype 7 ("mGluR7"). The present invention also relates to pharmaceutical composition comprising such compounds and their use for the treatment or prevention of...